| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.3% | 75.1% | ▼ -2.3% |
| Healthcare Services | 19.6% | 20.1% | ▲ +0.5% |
| Insurance | 1.0% | 1.0% | ● +0.0% |
| Chemicals & Petrochemicals | 0.7% | 0.7% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.1% | 75.2% | ▲ +0.1% |
| Healthcare Services | 20.1% | 20.9% | ▲ +0.8% |
| Insurance | 1.0% | 1.0% | ● -0.1% |
| Chemicals & Petrochemicals | 0.7% | 0.9% | ▲ +0.2% |
Comparing May 2026 → Jun 2026
| # | Stock | Sector | Weight (Jun 2026) |
|---|---|---|---|
| 1 | Syngene International Limited ₹8.31 Cr |
Healthcare Services | 0.82% |
| # | Stock | Sector | Last Weight (May 2026) |
|---|---|---|---|
| 1 | Alembic Pharmaceuticals Limited ₹11.85 Cr |
Pharmaceuticals & Biotechnology | 1.25% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Gland Pharma Limited ₹25.08 Cr |
Pharmaceuticals & Biotechnology | 1.20% | 2.48% | +1.28% |
| 2 | Sai Life Sciences Limited ₹35.36 Cr |
Pharmaceuticals & Biotechnology | 2.26% | 3.50% | +1.24% |
| 3 | Ajanta Pharma Limited ₹44.26 Cr |
Pharmaceuticals & Biotechnology | 3.99% | 4.38% | +0.39% |
| 4 | Corona Remedies Limited ₹23.01 Cr |
Pharmaceuticals & Biotechnology | 2.06% | 2.28% | +0.22% |
| 5 | Dr. Lal Path Labs Limited ₹16.09 Cr |
Healthcare Services | 1.38% | 1.59% | +0.21% |
| 6 | Vinati Organics Limited ₹8.55 Cr |
Chemicals & Petrochemicals | 0.65% | 0.85% | +0.20% |
| 7 | Aurobindo Pharma Limited ₹45.98 Cr |
Pharmaceuticals & Biotechnology | 4.37% | 4.55% | +0.18% |
| 8 | IPCA Laboratories Limited ₹25.78 Cr |
Pharmaceuticals & Biotechnology | 2.43% | 2.55% | +0.12% |
| 9 | Max Healthcare Institute Limited ₹7.90 Cr |
Healthcare Services | 0.71% | 0.78% | +0.07% |
| 10 | Emcure Pharmaceuticals Limited ₹32.64 Cr |
Pharmaceuticals & Biotechnology | 3.17% | 3.23% | +0.06% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Shilpa Medicare Ltd ₹24.35 Cr |
Pharmaceuticals & Biotechnology | 2.92% | 2.41% | -0.51% |
| 2 | Abbott India Limited ₹32.90 Cr |
Pharmaceuticals & Biotechnology | 3.65% | 3.26% | -0.39% |
| 3 | Sun Pharmaceutical Industries Limited ₹122.19 Cr |
Pharmaceuticals & Biotechnology | 12.42% | 12.09% | -0.33% |
| 4 | Divi's Laboratories Limited ₹17.11 Cr |
Pharmaceuticals & Biotechnology | 1.82% | 1.69% | -0.13% |
| 5 | Metropolis Healthcare Limited ₹14.51 Cr |
Healthcare Services | 1.57% | 1.44% | -0.13% |
| 6 | Pfizer Limited ₹12.46 Cr |
Pharmaceuticals & Biotechnology | 1.36% | 1.23% | -0.13% |
| 7 | Biocon Limited ₹11.36 Cr |
Pharmaceuticals & Biotechnology | 1.23% | 1.12% | -0.11% |
| 8 | Suraksha Diagnostic Ltd ₹9.14 Cr |
Healthcare Services | 1.01% | 0.90% | -0.11% |
| 9 | Fortis Healthcare Limited ₹32.44 Cr |
Healthcare Services | 3.31% | 3.21% | -0.10% |
| 10 | Alkem Laboratories Limited ₹19.52 Cr |
Pharmaceuticals & Biotechnology | 2.03% | 1.93% | -0.10% |
38 stocks — Jun 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹122.19 Cr |
Pharmaceuticals & Biotechnology |
12.09%
|
|
| 2 |
₹73.74 Cr |
Healthcare Services |
7.30%
|
|
| 3 |
₹47.64 Cr |
Pharmaceuticals & Biotechnology |
4.71%
|
|
| 4 |
₹47.33 Cr |
Pharmaceuticals & Biotechnology |
4.68%
|
|
| 5 |
₹45.98 Cr |
Pharmaceuticals & Biotechnology |
4.55%
|
|
| 6 |
₹44.26 Cr |
Pharmaceuticals & Biotechnology |
4.38%
|
|
| 7 |
₹39.60 Cr |
Pharmaceuticals & Biotechnology |
3.92%
|
|
| 8 |
₹37.79 Cr |
Pharmaceuticals & Biotechnology |
3.74%
|
|
| 9 |
₹35.36 Cr |
Pharmaceuticals & Biotechnology |
3.50%
|
|
| 10 |
₹32.90 Cr |
Pharmaceuticals & Biotechnology |
3.26%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.